| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2001;103:2942.)
© 2001 American Heart Association, Inc.
Clinical Investigation and Reports |
Atrioventricular Node Modification in Patients With Chronic Atrial Fibrillation
Role of Morphology of RR Interval Variation
From the Interventional Cardiology Unit, Department of Clinical Therapeutics, Alexandra Hospital, Athens University Medical School, Athens, Greece.
Correspondence to Dr Stelios Rokas, 41 Alkmanos St, Athens 115 28, Greece. E-mail katsioli{at}otenet.gr
 |
Abstract |
|---|
 Top Abstract IntroductionMethodsResultsDiscussionReferences |
|---|
Background—This study evaluates the role of RR interval distribution pattern as an outcome predictor of radiofrequency (RF) modification of atrioventricular (AV) node in chronic atrial fibrillation (AF) and attempts to elucidate the likely mechanism of rate control.
Methods and Results—Sixty-five patients with chronic AF underwent AV node modification. The RR interval distribution pattern was derived from 24-hour ECG recordings obtained before and after the procedure. The preablation pattern was bimodal (B) in 36 patients (55%) and unimodal (U) in 29 patients (45%). After the modification procedure, the B pattern shifted to U (78%) or became modified B (22%). The mean number of RF pulses delivered and the fluoroscopy time were n=8±5 and 24±11 minutes, respectively, in patients with B pattern versus n=18±7 and 45±17 minutes in patients with U pattern (P<0.001 for both). The location of successful ablation was posteroseptal and lower midseptal in 26 patients (81%) with B pattern versus 2 (13%) with U pattern (P<0.001). Mean and maximal ventricular rates and heart rate at peak exercise were reduced after the procedure in both groups (P<0.001 for all). Long-term success rate, AV block incidence, and pacemaker implantation rate were 89%, 0%, and 8%, respectively, in patients with B pattern versus 52% (P<0.001), 21% (P=0.006), and 48% (P<0.001) in patients with U pattern.
Conclusions—RF modification of the AV node is expected to be more effective, safe, and expeditious in patients with chronic AF and B RR interval distribution pattern. Posterior atrionodal input ablation may be the prevailing mechanism of rate control in these patients, whereas U-pattern patients may benefit from partial injury to the AV node.
Key Words: catheter ablation • atrioventricular node • fibrillation • intervals
|
Introduction |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Atrioventricular (AV) node modification has emerged as an effective means of rate control in symptomatic patients with chronic atrial fibrillation (AF) and rapid ventricular response despite pharmacological therapy.1 2 3 It has been suggested that ablation of the "slow pathway"1 or partial damage of the compact AV node2 3 might be the mechanisms that explain the benefit of this method. Because all patients in those studies had chronic AF, however, the underlying electrophysiological substrate of the AV node could not be evaluated by means of electrophysiological studies. In chronic AF, evidence is arising from RR interval analysis that a bimodal RR interval distribution pattern may indicate the presence of dual AV node physiology, whereas a unimodal pattern may be associated with orthodromic impulse propagation over the fast pathway alone.4 5 Therefore, we conducted a study to evaluate the possible role of the RR interval distribution pattern in the outcome of patients with chronic AF and rapid ventricular response who undergo radiofrequency (RF) modification of AV node conduction.
|
Methods |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Symptomatic patients with chronic AF and uncontrolled ventricular rates who were referred for RF modification of AV node conduction were eligible to enter the study protocol provided that (1) all antiarrhythmic (AA) drugs, including amiodarone, has been proved ineffective in converting AF to sinus rhythm or in controlling ventricular rate; (2) electrical cardioversion had failed to restore sinus rhythm; and (3) the patients agreed to discontinue all the AA agents before the RF modification procedure for a period >5 half-lives. Amiodarone was discontinued
2 months before the patients entered the study. The
following were criteria for exclusion from the study: (1) during the
period of discontinuation of the AA treatment, the presence of (a)
symptomatic bradyarrhythmia or pause >1.5 seconds,
(b) arrhythmia-related symptoms during the 24-hour ambulatory
ECG recording irrelevant to ventricular rate
augmentation >100 bpm during the recording, or (c) severe
symptoms at rest (eg, congestive heart failure) caused by
tachyarrhythmia; (2) left ventricular
function severely impaired (ejection fraction <0.40), angina pectoris,
or recent myocardial infarction; and (3) abnormal thyroid function or
severe systematic illness. In accordance with the Helsinki agreement,
the study was subject to the local ethical committee, and all patients
had given informed written consent.
Distribution Pattern of RR Intervals
The day before the RF modification procedure, a
24-hour ambulatory ECG recording was obtained from all patients
under conditions of usual daily activities and while the patients were
on no AA treatment. The data were recorded on tape. These analog
data were stored in a computer, and the method of heart
rate–stratified histogram was used for analysis of the
distribution pattern of all 24-hour RR intervals during
AF.6 The RR interval
distribution pattern may be unimodal, bimodal, or multimodal.
Bimodality is defined as the existence of 2 RR populations separated
distinctly by a visually estimated intersection point, the value of
which must be the same in 2 consecutive heart rate measurements. We
have previously described the technique of analysis
elsewhere.7
RF Modification Protocol
All RF modification procedures were performed by the
same operator, who was unaware of the patients’ RR interval
distribution pattern. Induction of permanent AV block was not our
intention in any case. Three quadripolar electrode catheters
were introduced percutaneously and positioned in the
right ventricular apex, His bundle region, and
coronary sinus (CS). CS venography was performed with a
multipurpose catheter to define the CS ostium. The sites of the His
bundle catheter and the CS ostium were identified and recorded on
cine film in the 30° right anterior oblique and 45° left anterior
oblique projections before the delivery of RF energy. The ablation
area from the His bundle region to the CS ostium was divided into 6
anatomic target regions (A2 to
P1). Current generated by a 500-kHz RF energy
source (Osypka 300S) was delivered between the distal 4-mm tip of a
deflectable 7F catheter (EPT Steerocath-T, EP Technologies) and a left
subscapular chest wall patch (7.25x1.5 in).
The same protocol of RF energy delivery was strictly followed in each patient, as follows: The ablation catheter was initially positioned in the most posterior region of the ablation area (P1), adjacent to the CS ostium. If the ablation attempts at this site were unsuccessful, the ablation catheter was gradually advanced anteriorly, toward sites P2, M1, M2, and A1. At each of those 5 sites, up to 5 RF pulses were delivered in a position slightly different from the previous one. If after the delivery of RF energy at a specific target region, transient reduction, either little or significant, of the ventricular rate occurred, 3 more RF pulses were delivered at this site before the catheter was moved to the next site. Power, impedance, and temperature were measured, displayed, and stored via an interface by use of a microprocessor. RF pulses were applied at a maximum of 50 W for 40 seconds to obtain a maximum distal tip temperature of 70°C. RF energy delivery was discontinued immediately in the case of impedance rise, catheter displacement, abrupt increase in RR interval, or occurrence of AV conduction block. The ablative procedure was considered successful when mean ventricular rate had been reduced by >20% and without exceeding the value of 130 bpm after administration of isoproterenol (2 µg/min). When this end point was not reached, the procedure was considered to have failed.
Measurement of Ventricular Rate and
Follow-Up
Measurements of ventricular rate derived
(1) from the whole 24-hour ECG recording in which the mean,
maximal, and minimum heart rates were calculated or (2) from
symptom-limited exercise treadmill testing at peak exercise. In all
cases, these rates were measured in the absence of AA drug therapy both
before and after the modification procedure.
After the procedure, the patients were admitted to the coronary care unit for 24 hours. Seven days after the procedure, a 24-hour ambulatory ECG recording was obtained under conditions of usual daily activities and was repeated after 3, 12, and 24 months during the follow-up period. An exercise stress test was carried out 3 months after the procedure. The follow-up period was not less than 8 months for any of the patients, and 60% of them were followed up for >2 years.
Statistical Analysis
Data are presented as mean±SD. Continuous
and categorical variables were compared by Student’s
t test and
2 test, respectively. Comparisons between
the 2 groups, for various periods of follow-up, were made by 1-way
ANOVA with Bonferroni transformation. Significance was set at
P<0.05.
|
Results |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
During the period between June 1996 and November 1999, 65 of 133 patients with AF who underwent RF modification fulfilled the inclusion criteria for participation in this study. Forty patients were men and 25 were women, with a mean age of 63±8 years (range 40 to 75 years). The mean duration of symptoms was 4.1±2.9 years (range 3 months to 19 years). Before the ablation procedure, a mean of 3.7±1.6 AA drugs had been ineffective in converting AF to sinus rhythm or controlling ventricular rate. All patients had a left ventricular ejection fraction >0.50, except 13 patients whose left ventricular ejection fractions ranged from 0.40 to 0.49. The analysis of all 24-hour RR intervals showed that 36 patients (55%) had a bimodal pattern of RR interval distribution, and 29 patients (45%) presented a unimodal pattern. The baseline characteristics of the study population are summarized in Table 1
.
|
Ablation Results
The ablation results are shown in
Table 2. During the early follow-up period (within 3 months after the procedure), 2 patients from each group
relapsed to rapid ventricular rates. Of those, 1 patient
from each group responded adequately to a combination of AA medications
(propranolol 40 mg BID and amiodarone 200 mg BID),
whereas the other 2 patients (1 from each group) underwent AV junction
ablation with subsequent pacemaker insertion. One patient with bimodal
pattern died of sudden death on day 45 after the procedure. The autopsy
findings were consistent with acute myocardial infarction. One
patient with unimodal pattern experienced 2 episodes of near syncope 3
months after the procedure. The ECG revealed intermittent complete
heart block.
|
In successful cases, the number of RF pulses ranged from 1 to 22 (mean 8.6±5.3) in patients with bimodal pattern and from 9 to 33 (mean 18.3±7.8) in patients with unimodal pattern (P<0.001), and the mean duration of fluoroscopy was 24.2±11.7 minutes (range 6 to 57 minutes) and 45±17.8 minutes (range 19 to 86 minutes), respectively (P<0.001). The location of successful ablation was posteroseptal and lower midseptal (P1–M1) in 26 patients (81%) with bimodal pattern versus 2 patients (13%) with unimodal pattern (P<0.001) and upper midseptal and anteroseptal (M2–A1) in 6 patients (19%) versus 13 patients (87%), respectively (P<0.001). The location of the target region where RF energy delivery resulted in high-degree AV block was midseptal in 3 and anteroseptal in another 3 patients.
Ventricular Rate Control
The mean and maximal ventricular rates
derived from 24-hour ambulatory ECG recordings before the RF
modification procedure and during the follow-up period in the 32
patients with bimodal pattern and in the 15 patients with unimodal
pattern who had a successful outcome are shown in
Figure 1. The baseline ventricular rate at peak
exercise was 190±26 bpm in patients with bimodal pattern and 182±19
bpm in patients with unimodal pattern
(P=NS). Three months after the
procedure, the respective values were 150±13 and 142±12 bpm
(P=0.058). The exercise
duration was increased from 4.7±1.9 to 7.6±1.7 minutes in patients
with bimodal pattern (P<0.001)
and from 5.1±2.4 to 7.4±1.7 minutes in patients with unimodal pattern
(P<0.001). All patients who
underwent successful RF modification remained asymptomatic
or minimally symptomatic, with no need for rate-limiting
medications.
|
P<0.01, 
P<0.05, 
P<0.001. Symbols *,
Patterns of Response to the Ablative
Procedure
The distribution pattern of RR intervals was assessed
at 7 days and at 3 months after the RF modification procedure in all
patients who had a successful outcome. In 25 of the 32 patients (78%)
with bimodal pattern, ablation resulted in elimination of the histogram
lying to the left of the intersection point, which represents
the RR population with short RR intervals. In other words, the bimodal
pattern shifted to a unimodal one
(Figure 2). In the remaining 7 patients (22%), ablation
resulted in displacement of the intersection point to the right
(Figure 3). In all patients with a unimodal preablation
pattern, this pattern remained unimodal after the successful procedure.
In the 2 patients with bimodal preablation pattern who relapsed to
rapid ventricular rates after 12 and 35 days, a 24-hour
ambulatory ECG recording was obtained immediately after the
recurrence. It is remarkable that in both patients, the first
24-hour ECG recording obtained 7 days after the procedure (that
is, before recurrence) exhibited a unimodal pattern, whereas
the recording obtained after the recurrence displayed a
bimodal pattern identical to the preablation pattern
(Figure 4).
|
|
|
|
Discussion |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Previous studies reported that adequate slowing of the ventricular rate can be achieved by posteroseptal RF ablation in
70% of patients with
chronic AF.1 2 The
ablation results cannot be predicted, however, and 25% of the
patients receive a permanent pacemaker because of
inadvertent AV
block.3 8 The
results of our study are comparable to those reported in the
aforementioned studies. Indeed, in all 65 patients studied, the overall
long-term success rate was 72%, and 26% of them received a permanent
pacemaker. When the preablation RR interval distribution pattern is
taken into consideration, however, the results of the AV node
modification demonstrate several statistically significant differences.
In patients presenting a bimodal preablation pattern, the
short-term success rate of AV node modification reaches a value of
94%, with no occurrence of procedural AV block. Conversely, only half
of the patients with a unimodal pattern had a successful outcome,
whereas the other half received a permanent pacemaker because of
inadvertent AV block or failure of the procedure. It is
also remarkable that in patients presenting a bimodal pattern,
successful AV node modification was achieved with smaller numbers of
ablative attempts and shorter fluoroscopy time, and the location of
successful RF energy delivery was the posterior and midseptal region of
the tricuspid annulus. By contrast, in patients presenting a
unimodal pattern, almost twice as many RF pulses and double the
fluoroscopy time were necessary, and the target area of successful RF
energy delivery was more anterior. These findings suggest that AV node
modification, when applied in patients with chronic AF and bimodal
distribution pattern, is more likely to be achieved successfully and
safely by posteroseptal and midseptal ablation, whereas in
patients presenting a unimodal pattern, a more aggressive and
strenuous procedure is needed for adequate rate control, with a high
risk of AV block.
The present study demonstrated that in 69% of the
patients with a bimodal preablation pattern, the population with a
short RR interval was almost eliminated (transition to unimodal
pattern) after a successful AV node modification. This finding might be
consistent with elimination of the posterior AV nodal input. In
25% of the patients with bimodal preablation pattern who had a
successful AV node modification, the postablation pattern remained
bimodal, but the point of intersection of the 2 RR populations was
displaced to the right. The resultant new population of short RR
intervals consisted of cycle lengths "less short" than the
preablation ones. Moreover, it is apparent that the preablation
population of short RR intervals has been almost eliminated
(Figure 3
). This modified bimodal pattern may
represent either a partial injury of the slow AV nodal input, a
nonspecific damage of the compact AV node, or a combined modification
of both posterior and anterior atrionodal inputs.
The findings of this study strengthen the notion that
the arising morphology of RR interval histograms reflects the
electrophysiological properties of a
specific anatomic or functional substrate as well as the alterations
that this substrate undergoes after the delivery of RF energy. This
concept is further supported by the fact that in the 2 patients with
relapse to rapid ventricular rates in whom a shift from
bimodality to unimodality was noted after the successful RF
modification, the bimodal pattern reappeared after the
recurrence, with exactly the same characteristics as those of
the preablation pattern
(Figure 4). Therefore, it is reasonable to presume that the
bimodality in the RR interval distribution pattern is associated with
rapid ventricular response to AF and that the
elimination of the population with short RR interval results in
ventricular rate control.
The issue that arises is to identify the mechanism by which rate control was achieved in half of the patients in whom dual AV node physiology is lacking. Chen et al9 attributed the postablation reduction of ventricular response to paroxysmal AF in patients without dual AV node physiology to the likely presence of a posterior atrionodal input with conduction properties almost similar to those of the anterior input, whereas Krahn et al10 suggested that half of these patients might benefit by nonspecific injury to the compact AV node. In the latter case, the ablation procedure must be more aggressive and is associated with a higher risk of AV block.
Rate Control
Our data displayed a trend for preservation of
the degree of maximal heart rate reduction throughout the follow-up
period in patients with a unimodal pattern compared with those
presenting a bimodal one. This consistency observed in
the unimodal-pattern patients may be attributed to partial injury to
the anterior atrionodal input, which is characterized by a low safety
factor of conduction and a long refractory
period.11 This notion is
also supported by the fact that the extent of reduction in
ventricular response during induced AF in patients with AV
nodal reentrant tachycardia who underwent slow-pathway
ablation depends on the functional properties of the anterior
atrionodal
input.12 13 14 15 16 17
Clinical Implications
The resultant differences in
parameters such as success rate, AV block incidence, number
of RF pulses delivered, fluoroscopy time, and location of successful
ablation site may reflect 2 different patterns of response to AV node
modification, depending on the morphology of RR interval variation.
Therefore, patients with chronic AF and rapid ventricular
response who present a bimodal preablation pattern of RR interval
distribution may be more suitable candidates for RF modification of the
AV node. By contrast, patients with a unimodal pattern may be rather
inappropriate candidates and should be referred primarily for AV
junction ablation and pacemaker implantation.
Limitations
Despite the detailed delineation of the AV junction and
the division of the ablation area into 6 anatomic target regions, the
accurate anatomic site of the compact portion of the AV node is not
strictly confined in
space.3 18 19 20
Therefore, in patients with bimodal pattern, it is not feasible to
determine precisely whether the tissue injuries caused by RF energy
affected only the posterior input, and some extent of damage to the
compact AV node cannot be ruled out. A second limitation arises from
the fact that the RR interval distribution analysis does not
provide 100% accuracy in the detection of dual AV node physiology, and
a unimodal pattern may possibly be associated with dual AV node
pathways.7
Although we acknowledge the limitations of this study, we believe that the weight of our evidence indicates that RF modification of the AV node can be used safely and effectively in patients with chronic AF in whom the preablation RR interval distribution pattern is bimodal. In addition, our data suggest that in patients with bimodal pattern, the prevailing mechanism of rate control after AV node modification may be the posterior atrionodal input ablation, whereas patients presenting a unimodal pattern may benefit from partial injury to the AV node.
Received November 1, 2000; revision received March 19, 2001; accepted March 29, 2001.
|
References |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
1. Feld G, Fleck P, Fujimura O, et al. Control of rapid ventricular response by radiofrequency catheter modification of the atrioventricular node in patients with medically refractory atrial fibrillation. Circulation. 1994;90:2299–2307.
2.
Williamson B, Man
K, Daoud E, et al. Radiofrequency catheter modification of
atrioventricular conduction to control the
ventricular rate during atrial fibrillation.
N Engl J Med. 1994;331:910–917.
3. Morady F, Hasse C, Strickberger S, et al. Long-term follow-up after radiofrequency modification of the atrioventricular node in patients with atrial fibrillation. J Am Coll Cardiol. 1997;27:113–121.
4.
Bootsma B, Hollen
A, Strackee J, et al. Analysis of RR intervals in patients with
atrial fibrillation at rest and during exercise.
Circulation. 1970;41:783–794.
5.
Olsson S, Cai N,
Dohnal M, et al. Non-invasive support for and characterization of
multiple intranodal pathways in patients with mitral valve disease and
atrial fibrillation. Eur Heart
J. 1986;7:320–333.
6. Cai N, Dohnal M, Olsson S. Methodological aspects of the use of heart rate stratified RR interval histograms in the analysis of atrioventricular conduction during atrial fibrillation. Cardiovasc Res. 1987;21:455–462.[Medline] [Order article via Infotrieve]
7. Rokas S, Gaitanidou S, Chatzidou S, et al. A non-invasive method for the detection of dual atrioventricular node physiology in chronic atrial fibrillation. Am J Cardiol. 1999;84:1442–1445.[Medline] [Order article via Infotrieve]
8. Feld GK. Radiofrequency catheter ablation versus modification of the AV node for control of rapid ventricular response in atrial fibrillation. J Cardiovasc Electrophysiol. 1995;6:217–228.[Medline] [Order article via Infotrieve]
9.
Chen SA, Lee SH,
Chiang CE, et al. Electrophysiological mechanisms
in successful radiofrequency catheter modification of
atrioventricular junction for patients with medically
refractory paroxysmal atrial fibrillation.
Circulation. 1996;93:1690–1701.
10.
Krahn A, Klein G,
Yee R, et al. Progressive anterior ablation in the coronary
sinus region: evidence to support the presence of a "slow pathway"
input in normal patients?
Circulation. 1997;96:3477–3483.
11.
Stein K, Lerman
B. Evidence for functionally distinct dual atrial inputs to the human
AV node. Am J Physiol. 1994;267:H2333–H2341.
12.
Markowitz S,
Stein K, Lerman B. Mechanism of ventricular rate control
after radiofrequency modification of atrioventricular
conduction in patients with atrial fibrillation.
Circulation. 1996;94:2856–2864.
13.
Kreiner G, Heinz
G, Siostrzonck P, et al. Effect of slow pathway ablation on
ventricular rate during atrial fibrillation Dependence on
electrophysiological properties of the fast
pathway. Circulation. 1996;93:277–283.
14. Della Bella P, Carbucicchio C, Tondo C, et al. Modulation of atrioventricular conduction by ablation of the "slow" atrioventricular node pathway in patients with drug-refractory atrial fibrillation or flutter. J Am Coll Cardiol. 1995;25:39–46.[Abstract]
15. Candy RC, Roman CA, Kessler DJ, et al. Selective radiofrequency ablation of the "slow" atrioventricular nodal pathway for control of the ventricular response to atrial fibrillation. Am J Cardiol. 1996;77:1358–1361.[Medline] [Order article via Infotrieve]
16. Tebbenjohanns J, Pfeiffer D, Schumacher B, et al. Slowing of the ventricular rate during atrial fibrillation by ablation of the slow pathway of AV nodal reentrant tachycardia. J Cardiovasc Electrophysiol. 1995;6:711–715.[Medline] [Order article via Infotrieve]
17.
Blank Z, Dhala A,
Sra J, et al. Characterization of atrioventricular
nodal behavior and ventricular response during atrial
fibrillation before and after a selective slow-pathway ablation.
Circulation. 1995;91:1086–1094.
18. Jackman WM, Beckman KJ, McCleland JH, et al. Treatment of supraventricular tachycardia due to atrioventricular nodal reentry by radiofrequency catheter ablation of slow-pathway conduction. N Engl J Med. 1992;327:313–318.[Abstract]
19.
Langberg JJ, Leon
A, Borganelli M. A randomized prospective comparison of anterior and
posterior approaches to radiofrequency catheter ablation of
atrioventricular nodal reentry tachycardia.
Circulation. 1993;87:1551–1556.
20.
Inoue S, Becker
A. Posterior extensions of the human compact
atrioventricular node: a neglected anatomic feature of
potential clinical significance.
Circulation. 1998;97:188–193.
This article has been cited by other articles:
 |
|
 |
|
  A. Bollmann, D. Husser, L. Mainardi, F. Lombardi, P. Langley, A. Murray, J. J. Rieta, J. Millet, S. B. Olsson, M. Stridh, et al. Analysis of surface electrocardiograms in atrial fibrillation: techniques, research, and clinical applications. Europace, November 1, 2006; 8(11): 911 - 926. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Zhang, S. Bharati, K. A. Mowrey, and T. N. Mazgalev His Electrogram Alternans Reveal Dual Atrioventricular Nodal Pathway Conduction During Atrial Fibrillation: The Role of Slow-Pathway Modification Circulation, February 25, 2003; 107(7): 1059 - 1065. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||